Clinical Trial Update: Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update of intravesical CGC (cabazitaxel, gemcitabine, and cisplatin) for urothelial carcinoma of the bladder, ongoing in Phase 1/Phase 2 with sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma of the Bladder

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemzar (gemcitabine)
• Jevtana (cabazitaxel)

Snippet

Sponsor: Guarionex J. Decastro | Conditions: Urothelial Carcinoma of the Urinary Bladder | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING